MENU
CVKD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cadrenal Therapeutics (CVKD) Earnings Date & Reports

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy... Show more

A.I. Advisor
published Earnings

CVKD is expected to report earnings to fall 25.67% to -138 cents per share on November 06

Cadrenal Therapeutics CVKD Stock Earnings Reports
Q3'25
Est.
$-1.39
Q2'25
Missed
by $0.61
Q4'24
Missed
by $1.88
Q3'24
Missed
by $2.06
Q2'24
Missed
by $2.13
The last earnings report on August 11 showed earnings per share of -187 cents, missing the estimate of -125 cents. With 13.96K shares outstanding, the current market capitalization sits at 25.54M.
View a ticker or compare two or three
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CVKD showed earnings on August 11, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com